Medifast Valuation

Is MED * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MED * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MED * (MX$374.64) is trading above our estimate of fair value (MX$363.54)

Significantly Below Fair Value: MED * is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MED *?

Key metric: As MED * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for MED *. This is calculated by dividing MED *'s market cap by their current earnings.
What is MED *'s PE Ratio?
PE Ratio	7x
Earnings	US$29.33m
Market Cap	US$205.04m

MED * key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.08x
Enterprise Value/EBITDA	1.3x
PEG Ratio	-0.09x

Price to Earnings Ratio vs Peers

How does MED *'s PE Ratio compare to its peers?

The above table shows the PE ratio for MED * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	31.5x
301108 Tongling Jieya Biologic Technology	38.2x	55.4%	CN¥2.2b
LFVN LifeVantage	41.9x	n/a	US$177.9m
6523 Dr. Wu Skincare	15.9x	2.9%	NT$7.2b
7823 Artnature	30.1x	n/a	JP¥26.3b
MED * Medifast	7x	-79.9%	Mex$205.0m

Price-To-Earnings vs Peers: MED * is good value based on its Price-To-Earnings Ratio (7x) compared to the peer average (39.5x).

Price to Earnings Ratio vs Industry

How does MED *'s PE Ratio compare vs other companies in the Global Personal Products Industry?

8 Companies	Price / Earnings	Estimated Growth	Market Cap

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: MED * is good value based on its Price-To-Earnings Ratio (7x) compared to the Global Personal Products industry average (24.5x).

Price to Earnings Ratio vs Fair Ratio

What is MED *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MED * PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	7x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate MED *'s Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.